Introducing our revolutionary Surround Optical Fiber Immunoassay (SOFIA) technology, a game-changing innovation in the field of immunoassay testing. Designed to provide unparalleled accuracy and efficiency, SOFIA leverages the power of optical fiber technology to deliver precise and reliable results in a fraction of the time compared to traditional immunoassay methods. With SOFIA, the testing process is simplified and streamlined, allowing for seamless integration into laboratory workflows. The surround optical fiber design enables multiplexing capabilities, enabling the simultaneous detection of multiple analytes in a single sample, saving time and resources. Its high sensitivity and specificity make it ideal for a wide range of applications, including clinical diagnostics, drug testing, and environmental monitoring. Our SOFIA technology offers superior performance, delivering consistent and reproducible results that healthcare professionals and researchers can rely on. Its compact and user-friendly design makes it suitable for both centralized and point-of-care testing settings, providing flexibility and convenience. In addition to its technical capabilities, SOFIA is also designed with cost-effectiveness in mind, offering a cost-efficient solution for immunoassay testing without compromising on quality. Experience the future of immunoassay testing with our Surround Optical Fiber Immunoassay technology and discover a new standard of accuracy and efficiency in your laboratory.

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T